DOJOLVI

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark DOJOLVI was filed as Word mark on 09/12/2019 at the World Intellectual Property Organization.

Trademark Details Last update: March 11, 2022

Trademark form Word mark
File reference 1497190
Countries Canada China Colombia European Community India Japan South Korea Mexico Turkey
Base trademark US No. 88352451, March 22, 2019
Application date September 12, 2019
Expiration date September 12, 2029

Trademark owner

60 Leveroni Court
Novato CA 94949
US

Trademark representatives

1299 Pennsylvania Avenue NW, Suite 700 Washington DC 20004 US

goods and services

05 Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)

Trademark history

Date Document number Area Entry
March 2, 2022 2022/10 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 2, 2021 2021/22 Gaz MX Rejection
March 4, 2021 2021/10 Gaz CA Rejection
December 23, 2020 2020/52 Gaz TR Rejection
December 17, 2020 2020/51 Gaz JP Rejection
December 7, 2020 2020/50 Gaz KR Rejection
September 29, 2020 2020/40 Gaz IN Rejection
July 9, 2020 2020/28 Gaz CO Rejection
June 22, 2020 2020/26 Gaz EM Rejection
March 13, 2020 2020/12 Gaz CN Rejection
September 12, 2019 2019/44 Gaz US Registration

ID: 141497190